Hair Today, Progress Tomorrow: Understanding Why Finasteride Works on Biology's Schedule
Photo: Agostino Carracci, Public domain, via Wikimedia Commons
Impatience is one of the most predictable challenges men face when starting finasteride. You have made a decision, filled a prescription, and committed to a daily pill — and then, weeks pass with little visible change. For many men in the United States, this quiet waiting period becomes the reason they abandon treatment before it ever has a chance to work.
The biology here is not mysterious, but it is frequently misunderstood. Finasteride does not act like a topical treatment you apply directly to a thinning patch. It intervenes at a hormonal level, and the hair follicles it is working to rescue operate on a timeline entirely their own. Understanding that timeline — and what is actually happening beneath your scalp right now — may be the most useful thing you can do for your long-term treatment success.
The DHT Problem and How Finasteride Addresses It
Male pattern hair loss, clinically known as androgenetic alopecia, is driven primarily by dihydrotestosterone, or DHT. This androgen is produced when an enzyme called 5-alpha reductase converts testosterone into DHT. In men who are genetically predisposed to hair loss, DHT binds to receptors in scalp follicles and gradually miniaturizes them — a slow process in which each successive hair grows thinner, shorter, and more fragile until the follicle eventually stops producing visible hair altogether.
Finasteride works by inhibiting 5-alpha reductase, which reduces circulating DHT levels by approximately 70 percent in most men. This is significant and measurable. Within the first few weeks of consistent use, serum DHT levels drop substantially. In that narrow biochemical sense, finasteride works quickly.
The problem is that reducing DHT does not immediately reverse the damage already done. Miniaturized follicles that have been suppressed for months or years do not snap back overnight. They require sustained exposure to a lower-DHT environment before they can begin recovering their function — and that recovery, when it comes, happens according to the hair growth cycle, not your calendar.
The Hair Growth Cycle: Your Follicles Have Their Own Schedule
Every hair follicle on your scalp cycles through three distinct phases. The anagen phase is the active growth period, lasting anywhere from two to six years in healthy follicles. The catagen phase is a brief transitional period lasting a few weeks. The telogen phase is a resting period of roughly three months, after which the old hair sheds and a new growth cycle begins.
In men experiencing DHT-driven hair loss, follicles spend progressively less time in anagen and more time in telogen. The hairs they produce become finer with each cycle. When finasteride lowers DHT levels, it creates the conditions for follicles to re-enter and sustain longer anagen phases — but only follicles that are still alive and capable of recovery will respond, and only after cycling through their existing telogen phase first.
This is why results take time. A follicle currently in its resting phase must complete that phase, shed its existing hair, and then begin a new growth cycle under improved hormonal conditions before you will see any change. Depending on where individual follicles are in their cycle when you begin treatment, this process can take many months to manifest visibly across your scalp.
A Realistic Week-by-Week Framework for Your First Year
Weeks 1 through 8: Finasteride is actively suppressing DHT. You are unlikely to notice any visible changes to your hair. Some men report a temporary increase in shedding during this period — a phenomenon sometimes called a "dread shed" in online communities. This is a normal and documented occurrence that reflects follicles cycling out of telogen and transitioning toward new growth. It is not a sign that the medication is failing.
Months 3 through 6: This is the period during which many men abandon treatment, and it is also the period when the biological groundwork is being laid for future results. Some men begin to notice stabilization — meaning hair loss appears to have slowed or stopped — before they see any regrowth. Stabilization is itself a meaningful outcome and should be recognized as such.
Months 6 through 9: Clinical trials, including the landmark studies submitted to the FDA during finasteride's approval process, identified this window as the point at which a meaningful percentage of men begin to observe visible improvement. For some, this means reduced shedding. For others, it means finer hairs in previously thinning areas beginning to thicken.
Months 9 through 12: The one-year mark is widely cited as the earliest point at which a comprehensive assessment of finasteride's effectiveness is clinically appropriate. By this stage, most follicles that are capable of responding to reduced DHT levels will have had the opportunity to complete at least one new growth cycle. Results vary considerably between individuals, but the data from multi-year clinical trials consistently shows that men who remain on finasteride through the first year achieve better outcomes than those who stop early.
Why Photographs Matter More Than Mirrors
One practical recommendation that physicians consistently offer to men on finasteride is to document their hair status with photographs taken under consistent lighting conditions every four to six weeks. The human eye is poorly equipped to detect gradual change — particularly in something as emotionally charged as hair loss. Men who rely solely on daily mirror checks frequently underestimate their progress, because the changes finasteride produces accumulate slowly and are easy to overlook in real time.
A side-by-side comparison of photographs taken three or six months apart often reveals progress that was invisible day to day. This documentation practice also provides useful information for conversations with your prescribing physician if you have questions about your response to treatment.
Managing Expectations Without Abandoning Them
Finasteride is not a guaranteed solution for every man, and it is not a treatment that reverses years of hair loss in all cases. The evidence supports its effectiveness for slowing and in many cases partially reversing androgenetic alopecia — but the degree of response varies based on genetics, the extent of loss at the time treatment begins, age, and individual hormonal factors.
What the evidence does not support is the common assumption that a lack of visible results at three months means the treatment is not working. For the vast majority of men, three months is simply not long enough for the biological processes finasteride initiates to produce visible outcomes.
If you are currently in that frustrating early window, the most evidence-aligned course of action is to continue treatment consistently, document your baseline and progress photographically, and schedule a follow-up with your prescribing physician at the six-month mark. The biology is working on its own timeline — and that timeline, though slower than any of us would prefer, is one that has been validated by decades of clinical research.
